Pages that link to "Item:Q664918"

The following pages link to A new mathematical model for optimizing the combination between antiangiogenic and cytotoxic drugs in oncology (Q664918):

Displaying 7 items.

• Transient alleviation of tumor hypoxia during first days of antiangiogenic therapy as a result of therapy-induced alterations in nutrient supply and tumor metabolism -- analysis by mathematical modeling (Q1642627) (← links)
• Mathematical modelling of chemotherapy combined with bevacizumab (Q1681955) (← links)
• Maximum tolerated dose versus metronomic scheduling in the treatment of metastatic cancers (Q1790751) (← links)
• Combined therapy for treating solid tumors with chemotherapy and angiogenic inhibitors (Q2033852) (← links)
• A novel numerical and artificial intelligence based approach to study anti-angiogenic drugs: endostatin (Q2109887) (← links)
• Optimizing the delivery of combination therapy for tumors: A mathematical model (Q2977889) (← links)
• Mathematical model of cancer growth controled by metronomic chemotherapies (Q3451669) (← links)